Angiotensin II type 1 receptors and oestrogen status: interaction or dissociation?
Zhuo
Jia L
JL
D057911:Angiotensin Receptor Antagonists; D000818:Animals; D000959:Antihypertensive Agents / Q000037:antagonists & inhibitors*; D001713:Biphenyl Compounds / Q000037:antagonists & inhibitors*; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000502:physiology*; D004967:Estrogens / Q000378:metabolism* / Q000494:pharmacology*; D006801:Humans; D000077405:Irbesartan; D051381:Rats; D011918:Rats, Inbred SHR; D044140:Receptor, Angiotensin, Type 1; D012084:Renin-Angiotensin System / Q000187:drug effects; D013223:Statistics as Topic; D013777:Tetrazoles / Q000037:antagonists & inhibitors*
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D004967:Estrogens; D044140:Receptor, Angiotensin, Type 1; D013777:Tetrazoles; D000077405:Irbesartan